A European innovation system in pharmaceuticals?

International Journal of Biotechnology

Volumn 4, Issue 1, 2002, Pages 96-114

  Howells, Jeremy ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Institutions; Pharmaceuticals; Regulation; Systems of innovation; Technological innovation

Indexed keywords

LAWS AND LEGISLATION; REGULATORY COMPLIANCE; RESEARCH AND DEVELOPMENT MANAGEMENT; TECHNOLOGY TRANSFER;

TECHNOLOGICAL INNOVATIONS;

DRUG PRODUCTS;

EID: 0036307991     PISSN: 09636048     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJBT.2002.000182     Document Type: Article

References (49)

1. Japan: A new national system of innovation?
2. Introduction
3. National innovation systems: A retrospective on a study
4. Technical innovation and national systems
5. On the nature, function and composition of technological systems
6. The technological system for factory automation: An international comparison
7. Regional systems of innovation?
8. Innovation systems and policy in a global economy
9. The new licensing system for pharmaceuticals marketed in the European union
10. The rough and the smooth of EC drug regulation
11. Drugs groups fear losses from cheap imports
12. Pharmaceuticals and Europe 1992: The dynamics of industrial change
13. Pharmaceutical manufacturing - A competitive advantage
14. Primary production - Asset or liability?
15. Rationalising production in Europe
16. SmithKline Beecham: Global push and repositioning
17. Improving clinical trials cost management in biotech companies
18. Active ingredients manufacture - Time to reconsider?
19. A dose of strong medicine
20. Japan: Joint ventures
21. Joint ventures and collaboration in the biotechnology industry
22. Multifirm strategies in the US pharmaceutical industry
23. Marketing and R&D strategies for biotechnology firms in the USA
24. R&D collaboration as a global competitive tactic - Biotechnology and the ethical pharmaceutical industry
25. Inter-firm collaboration: The case of Japanese biotechnology
26. Strategic alignment and organizational options in biotechnology firms
27. The governance of innovation: Vertical integration and collaborative arrangements in the biotechnology industry
28. Biotechnology: The emerging battlefield for US and Japanese pharmaceutical companies
29. A shift to external alliances for product development in the pharmaceutical industry
30. The globalisation of research and development
31. The problem with patents
32. Obtaining industry control: The case of the pharmaceutical distribution industry
33. The 'National System of Innovation' in historical perspective
34. Toward a clarification of system analysis in the social sciences
35. Technical innovation and national systems
36. Large firms in the production of the world's technology: An important case of 'non-globalisation
37. Localised production of technology for global markets
38. Systems of innovation approaches - Their emergence and characteristics
39. Industrial governance structures, innovation strategies, and the case of Japan: Sectoral or cross-national comparative analysis?
40. Institutions and organizations in systems of innovation